PET/CT in diagnosis of dementia

Amyloid imaging of Lewy body-associated disorders

(2010) Erin R. Foster et al.   MOVEMENT DISORDERS

Striatal Aβ peptide deposition mirrors dementia and differentiates DLB and PDD from other Parkinsonian syndromes

(2010) M.E. Kalaitzakis et al.   NEUROBIOLOGY OF DISEASE

Update on Frontotemporal Dementia

(2010) Zoe Arvanitakis   NEUROLOGIST

Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo

(2010) J. C. Klein et al.   NEUROLOGY

Increased fibrillar amyloid-  burden in normal individuals with a family history of late-onset Alzheimer's

(2010) L. Mosconi et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

2009 Alzheimer's disease facts and figures

(2009)   Alzheimers & Dementia

Influence of Cognitive Status, Age, and APOE-4 Genetic Risk on Brain FDDNP Positron-Emission Tomography Imaging in Persons Without Dementia

(2009) Gary W. Small et al.   ARCHIVES OF GENERAL PSYCHIATRY

Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease

(2009) Clifford R. Jack et al.   BRAIN

Association between FDG uptake, CSF biomarkers and cognitive performance in patients with probable Alzheimer’s disease

(2009) Sönke Arlt et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Relationship of Cerebrospinal Fluid Markers to 11C-PiB and 18F-FDDNP Binding

(2009) N. Tolboom et al.   JOURNAL OF NUCLEAR MEDICINE

FDDNP binding using MR derived cortical surface maps

(2009) H.D. Protas et al.   NEUROIMAGE

Follow-up of [11C]PIB uptake and brain volume in patients with Alzheimer disease and controls

(2009) N. M. Scheinin et al.   NEUROLOGY

Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET

(2009) H. Shimada et al.   NEUROLOGY

Conversion of amyloid positive and negative MCI to AD over 3 years: An 11C-PIB PET study

(2009) A. Okello et al.   NEUROLOGY

Fibrillar amyloid-  burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease

(2009) E. M. Reiman et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Assessment of β-Amyloid in a Frontal Cortical Brain Biopsy Specimen and by Positron Emission Tomography With Carbon 11–Labeled Pittsburgh Compound B

(2008) Ville Leinonen   ARCHIVES OF NEUROLOGY

Frequent Amyloid Deposition Without Significant Cognitive Impairment Among the Elderly

(2008) Howard Jay Aizenstein et al.   ARCHIVES OF NEUROLOGY

CSF phosporylated TAU protein levels correlate with cerebral glucose metabolism assessed with PET in Alzheimer's disease

(2008) R. Ceravolo et al.   BRAIN RESEARCH BULLETIN

Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography

(2008) P Edison et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Multicenter Standardized 18F-FDG PET Diagnosis of Mild Cognitive Impairment, Alzheimer's Disease, and Other Dementias

(2008) L. Mosconi et al.   JOURNAL OF NUCLEAR MEDICINE

Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET study

(2008) Paul Edison et al.   NEUROBIOLOGY OF DISEASE

Imaging amyloid deposition in Lewy body diseases

(2008) S. N. Gomperts et al.   NEUROLOGY

PET imaging of amyloid deposition in patients with mild cognitive impairment

(2007) Anton Forsberg et al.   NEUROBIOLOGY OF AGING

[11C]PIB binding in Parkinson's disease dementia

(2007) Walter Maetzler et al.   NEUROIMAGE